Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

Quell Therapeutics Limited
Sponsor

Quell Therapeutics Limited

United Kingdom 3rd Floor, Translation And Innovation Hub, 84 Wood Lane, W12 0BZ, United Kingdom

About the sponsor

Clinical research in liver transplantation with attention to graft rejection and immune tolerance in A2-mismatch transplant settings.

  • Prevention of liver transplant rejection
  • Allogeneic immune regulation
  • Post-transplant immunological compatibility

The sponsor’s transplant-focused work centers on immune-mediated complications that affect organ acceptance and long-term transplant outcomes.

About Specializations

Quell Therapeutics Limited runs clinical trials in conditions such as Systemic scleroderma, Rheumatoid arthritis, Liver transplant rejection, among others.

Recruiting now

Ongoing trials

Clinical trials run by this sponsor – those enrolling participants first.

Condition
Country
City
Type of trial
Recruitment status
Quick filters

2 clinical trials

Systemic scleroderma+1

Recruiting
InvestigationalNo placebo
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Sponsor:Quell Therapeutics Limited

Liver transplant rejection

Not recruiting
InvestigationalNo placebo
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Autologous T Regulatory Cells Expressing An Hla-A2-Specific Chimeric Antigen Receptor
  • Sponsor:Quell Therapeutics Limited

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Join now →
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.